Discussions

Next generation probiotics (NGPs), also referred to live biotherapeutic products (LBPs), can target specific diseases and can be used as a revolutionary class of medicines for therapeutic purposes. NGPs are usually derived from next-generation sequencing (NGS) and bioinformatics analysis. With our state-of-the-art technology and industry-leading expertise, Creative Biolabs has developed an unparalleled platform for NGP isolation, identification, and functional characterization. Currently, we have discovered a wide range of potential NGPs, including Akkermansia muciniphila strain, for pre-clinical, clinical, and commercial applications.

Alzheimer's disease (AD) is one of the most concerning neurodegenerative diseases. As a global leading CRO company focusing on neuroscience research, Creative Biolabs has an advanced technology platform providing various kinds of AD in vitro disease model services to help accelerate AD studies.

Creative Biolabs is the specialist provider of an AD biomarker assay. We have a professional team of scientists to provide a comprehensive range of rapid AD Biomarker assays through standard experimental procedures to meet the different needs of AD research.

Creative Biolabs is always the leader in 3D neural spheroids culture technology services and offers a variety of technologies to help you grow 3D neural spheroids quickly and efficiently. In addition, we also provide functional tests and a one-stop service for your research and development to bring more physiological relevance.

Based on the leading-edge platform and profound knowledge in cell immortalization, the specialized and dedicated team at Creative Biolabs provides world-class solutions for B cell immortalization and helps you obtain the desired results. Our state-of-the-art technologies and highly qualified personnel guarantee that we can deliver maximum quality and flexibility in all phases of the service lifecycle.